Jim Wassil Vaxcyte, Inc. (PCVX) insider trading activity

Jim Wassil is CHIEF OPERATING OFFICER of Vaxcyte, Inc.. Currently has a direct ownership of 151,916 shares of PCVX, which is worth approximately $10.8 Million. The most recent transaction as insider was on Mar 03, 2025, when has been sold 3,015 shares (Common Stock) at a price of $72.1 per share, resulting in proceeds of $217,381. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 152K

26.15% 3M change

30.53% 12M change

Total Value Held $10.8 Million

Jim Wassil Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 03 2025	SELL Payment of exercise price or tax liability	$217,381 $72.1 p/Share	3,015 Reduced 1.95%	151,916 Common Stock
Mar 03 2025	SELL Open market or private sale	$587,600 $73.45 p/Share	8,000 Reduced 4.91%	154,931 Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	$31,120 $3.89 p/Share	8,000 Added 4.68%	162,931 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$302,229 $73.02 p/Share	4,139 Reduced 2.6%	154,931 Common Stock
Feb 28 2025	BUY Grant, award, or other acquisition	$412,489 $73.02 p/Share	5,649 Added 3.43%	159,070 Common Stock
Feb 27 2025	BUY Grant, award, or other acquisition	-	21,726 Added 12.4%	153,421 Common Stock
Feb 03 2025	SELL Open market or private sale	$694,960 $86.87 p/Share	8,000 Reduced 3.74%	205,695 Common Stock
Feb 03 2025	BUY Exercise of conversion of derivative security	$19,360 $2.42 p/Share	8,000 Added 3.61%	213,695 Common Stock
Jan 02 2025	SELL Open market or private sale	$669,360 $83.67 p/Share	8,000 Reduced 3.74%	205,695 Common Stock
Jan 02 2025	BUY Exercise of conversion of derivative security	$19,360 $2.42 p/Share	8,000 Added 3.61%	213,695 Common Stock
Dec 31 2024	SELL Bona fide gift	-	74,000 Reduced 35.98%	131,695 Common Stock
Dec 02 2024	SELL Open market or private sale	$744,480 $93.06 p/Share	8,000 Reduced 3.74%	205,695 Common Stock
Dec 02 2024	BUY Exercise of conversion of derivative security	$19,360 $2.42 p/Share	8,000 Added 3.61%	213,695 Common Stock
Nov 01 2024	SELL Open market or private sale	$861,440 $107.68 p/Share	8,000 Reduced 3.74%	205,695 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$19,360 $2.42 p/Share	8,000 Added 3.61%	213,695 Common Stock
Oct 28 2024	BUY Exercise of conversion of derivative security	$66,343 $13.14 p/Share	5,049 Added 2.4%	205,695 Common Stock
Oct 01 2024	SELL Open market or private sale	$913,840 $114.23 p/Share	8,000 Reduced 3.83%	200,646 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$19,360 $2.42 p/Share	8,000 Added 3.69%	208,646 Common Stock
Sep 16 2024	SELL Open market or private sale	$1,160,500 $116.05 p/Share	10,000 Reduced 4.75%	200,646 Common Stock
Sep 16 2024	BUY Exercise of conversion of derivative security	$24,200 $2.42 p/Share	10,000 Added 4.51%	211,958 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$610,781 $110.15 p/Share	5,545 Reduced 2.67%	201,958 Common Stock
Sep 03 2024	SELL Open market or private sale	$1,129,700 $112.97 p/Share	10,000 Reduced 4.6%	207,503 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$24,200 $2.42 p/Share	10,000 Added 4.4%	217,503 Common Stock
Aug 01 2024	SELL Open market or private sale	$237,450 $79.15 p/Share	3,000 Reduced 1.43%	207,503 Common Stock
Jul 01 2024	SELL Open market or private sale	$229,680 $76.56 p/Share	3,000 Reduced 1.41%	210,503 Common Stock

Also insider at

ICVX

Icosavax, Inc. Healthcare

Jim Wassil

CHIEF OPERATING OFFICER

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Value

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX

Account